Cargando…

Time course of red cell volume and plasma volume over six months in compensated chronic heart failure

BACKGROUND: In patients with chronic heart failure (CHF), volume overload is usually described as an expansion of plasma volume (PV). Additional red cell volume (RCV) expansion also occurs in a relevant fraction of compensated CHF patients. So far, little is known about the stability of these vascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahlgrim, Christoph, Seiler, Florian, Birkner, Philipp, Staudacher, Dawid Leander, Grundmann, Sebastian, Bode, Christoph, Pottgiesser, Torben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006671/
https://www.ncbi.nlm.nih.gov/pubmed/33403801
http://dx.doi.org/10.1002/ehf2.13179
_version_ 1783672352637190144
author Ahlgrim, Christoph
Seiler, Florian
Birkner, Philipp
Staudacher, Dawid Leander
Grundmann, Sebastian
Bode, Christoph
Pottgiesser, Torben
author_facet Ahlgrim, Christoph
Seiler, Florian
Birkner, Philipp
Staudacher, Dawid Leander
Grundmann, Sebastian
Bode, Christoph
Pottgiesser, Torben
author_sort Ahlgrim, Christoph
collection PubMed
description BACKGROUND: In patients with chronic heart failure (CHF), volume overload is usually described as an expansion of plasma volume (PV). Additional red cell volume (RCV) expansion also occurs in a relevant fraction of compensated CHF patients. So far, little is known about the stability of these vascular volumes and possible volume excess in compensated CHF patients over time. METHODS AND RESULTS: This study aims at quantification of blood volume and its components, RCV and PV (raw values and adjusted for sex and anthropometric characteristics, expressed as per cent of the expected normal value), using an abbreviated carbon monoxide (CO) rebreathing method (aCORM) in 14 patients (two women) with systolic CHF at baseline and at a follow‐up visit after approximately 6 months. While a vast heterogeneity was observed concerning RCV (82% to 134% of normalized alues) and PV (72% to 131% of normalized values), the vascular volumes showed a mean change of 1.2% and −1.3% after a mean follow‐up of 183 days. CONCLUSIONS: The vascular volumes including individual volume excess appear to be stable in compensated CHF patients. The reason for this individual volume response concerning both RCV and PV in CHF remains unclear and deserves further clarification.
format Online
Article
Text
id pubmed-8006671
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80066712021-04-01 Time course of red cell volume and plasma volume over six months in compensated chronic heart failure Ahlgrim, Christoph Seiler, Florian Birkner, Philipp Staudacher, Dawid Leander Grundmann, Sebastian Bode, Christoph Pottgiesser, Torben ESC Heart Fail Short Communications BACKGROUND: In patients with chronic heart failure (CHF), volume overload is usually described as an expansion of plasma volume (PV). Additional red cell volume (RCV) expansion also occurs in a relevant fraction of compensated CHF patients. So far, little is known about the stability of these vascular volumes and possible volume excess in compensated CHF patients over time. METHODS AND RESULTS: This study aims at quantification of blood volume and its components, RCV and PV (raw values and adjusted for sex and anthropometric characteristics, expressed as per cent of the expected normal value), using an abbreviated carbon monoxide (CO) rebreathing method (aCORM) in 14 patients (two women) with systolic CHF at baseline and at a follow‐up visit after approximately 6 months. While a vast heterogeneity was observed concerning RCV (82% to 134% of normalized alues) and PV (72% to 131% of normalized values), the vascular volumes showed a mean change of 1.2% and −1.3% after a mean follow‐up of 183 days. CONCLUSIONS: The vascular volumes including individual volume excess appear to be stable in compensated CHF patients. The reason for this individual volume response concerning both RCV and PV in CHF remains unclear and deserves further clarification. John Wiley and Sons Inc. 2021-01-05 /pmc/articles/PMC8006671/ /pubmed/33403801 http://dx.doi.org/10.1002/ehf2.13179 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Short Communications
Ahlgrim, Christoph
Seiler, Florian
Birkner, Philipp
Staudacher, Dawid Leander
Grundmann, Sebastian
Bode, Christoph
Pottgiesser, Torben
Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
title Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
title_full Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
title_fullStr Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
title_full_unstemmed Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
title_short Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
title_sort time course of red cell volume and plasma volume over six months in compensated chronic heart failure
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006671/
https://www.ncbi.nlm.nih.gov/pubmed/33403801
http://dx.doi.org/10.1002/ehf2.13179
work_keys_str_mv AT ahlgrimchristoph timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure
AT seilerflorian timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure
AT birknerphilipp timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure
AT staudacherdawidleander timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure
AT grundmannsebastian timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure
AT bodechristoph timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure
AT pottgiessertorben timecourseofredcellvolumeandplasmavolumeoversixmonthsincompensatedchronicheartfailure